Celldex Therapeutics, Inc.

US$29.87As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:CLDXHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (4.47%)
Div yield —
ROE (49.54%)
Biotechnology
Beta (5Y) 1.03
PE TTM —
TSR TTM 11.75%
Mkt cap US$2.346B
ROIC (33.17%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$30
(0.32%)
(59.72%)
Hold 2|10|3|9|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.50
0.49
0.52
0.55
18.70%
22.43%
25.33%
20.71%
Revenue$M
165.7
167.0
171.7
175.5
2.11%
4.70%
1.83%
5.06%
Peers (US$2.346B)
Cap (US$)
PE
2.280B
—
2.365B
6.044x
Capital
TTM
5Y
10Y
Leveragex
0.617
0.693
0.668
EBIT/Intx
1.487
0.287
0.376
Own earn%
(1.10)
69.22
67.71
Sh yield%
22.86
47.16
46.26
Owners
Insiders/Inst%
12.23
74.52
Short interest%
5.70
SBC / revenue%
1.60
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
23–27
$1 testx
—
Incr. ROIC%
0